Do cells need CDK2 and ... Bcr-Abl?

被引：21

作者：

Blagosklonny, MV ^{[1
]}

机构：

[1] New York Med Coll, Brander Canc Res Inst, Valhalla, NY 10595 USA

来源：

CELL DEATH AND DIFFERENTIATION | 2004年 / 11卷 / 03期

关键词：

D O I：

10.1038/sj.cdd.4401361

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

[No abstract available]

引用

页码：249 / 251

页数：3

共 47 条

[1] SIGNALING BY ABL ONCOGENES THROUGH CYCLIN D1 [J].

AFAR, DEH ;

MCLAUGHLIN, J ;

SHERR, CJ ;

WITTE, ON ;

ROUSSEL, MF .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (21) :9540-9544

[2]

Aleem E, 2004, CELL CYCLE, V3, P35

[3] Bcr-Abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome c and activation of caspase-3 [J].

Amarante-Mendes, GP ;

Kim, CN ;

Liu, L ;

Huang, Y ;

Perkins, CL ;

Green, DR ;

Bhalla, K .

BLOOD, 1998, 91 (05) :1700-1705

[4] Bcl-2-independent Bcr-Abl-mediated resistance to apoptosis:: protection is correlated with up regulation of Bcl-xL [J].

Amarante-Mendes, GP ;

McGahon, AJ ;

Nishioka, WK ;

Afar, DEH ;

Witte, ON ;

Green, DR .

ONCOGENE, 1998, 16 (11) :1383-1390

[5] Anti-apoptotic oncogenes prevent caspase-dependent and independent commitment for cell death [J].

Amarante-Mendes, GP ;

Finucane, DM ;

Martin, SJ ;

Cotter, TG ;

Salvesen, GS ;

Green, DR .

CELL DEATH AND DIFFERENTIATION, 1998, 5 (04) :298-306

[6] Cdk2 knockout mice are viable [J].

Berthet, C ;

Aleem, E ;

Coppola, V ;

Tessarollo, L ;

Kaldis, P .

CURRENT BIOLOGY, 2003, 13 (20) :1775-1785

[7] Cyclotherapy Protection of Normal Cells and Unshielding of Cancer Cells [J].

Blagosklonny, Mikhail V. ;

Darzynkiewicz, Zbigniew .

CELL CYCLE, 2002, 1 (06) :375-382

[8] The Restriction Point of the Cell Cycle [J].

Blagosklonny, Mikhail V. ;

Pardee, Arthur B. .

CELL CYCLE, 2002, 1 (02) :103-110

[9] Cell senescence and hypermitogenic arrest [J].

Blagosklonny, MV .

EMBO REPORTS, 2003, 4 (04) :358-362

[10] The Hsp90 inhibitor geldanamycin selectively sensitizes Bcr-Abl-expressing leukemia cells to cytotoxic chemotherapy [J].

Blagosklonny, MV ;

Fojo, T ;

Bhalla, KN ;

Kim, JS ;

Trepel, JB ;

Figg, WD ;

Rivera, Y ;

Neckers, LM .

LEUKEMIA, 2001, 15 (10) :1537-1543

← 1 2 3 4 5 →